6505--FY26QTR4 OPTUM HAZARDOUS DRUG COMPOUNDING, TOMS RIVER, NJ (VA-26-00071687)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), on behalf of the NJHCS Toms River, NJ Campus, has issued a Special Notice indicating its intent to award a Firm Fixed Price (FFP) sole source contract to OPTUM PHARMACY 801, INC. for Hazardous Drug Compounding services. This notice is not a request for quotes, but other responsible sources may submit capability statements demonstrating their ability to provide the required services.
Scope of Work
The awarded contractor will provide hazardous drug compounding services, including:
- Preparing prescriptions based on valid VA provider orders (electronically signed and VA pharmacist verified).
- Receiving prescriptions via fax by 11:30 AM the day prior to intended treatment.
- Compounding chemotherapy prescriptions according to recognized pharmacy regulatory guidelines.
- Ensuring shipping complies with manufacturers' requirements for drug stability and refrigeration.
- Packaging with all required labeling to identify hazardous contents.
- Delivering the final product to the Toms River facility no later than 8:00 AM on the day of treatment.
- Complying with USP 797, USP 800, and FDA insanitary guideline regulations, using aseptic technique.
- Ensuring the final product is compatible with Equishield closed system transfer devices and attaching VA Toms River Clinic preferred tubing.
- Providing specific hazardous drugs and related items, including Azacitidine, Bortezomib, Carboplatin, Cisplatin, Cyclophosphamide, Irinotecan, Oxaliplatin, Carfilzomib, Docetaxel, Gemcitabine, Pemetrexed, Trastuzumab, Fluorouracil, Etoposide, Doxorubicin, Vincristine, Mesna, Brentuximab, Dextrose solutions, and various administration sets/connectors.
Contract Details
- Contract Type: Firm Fixed Price (FFP)
- Intended Awardee: OPTUM PHARMACY 801, INC. (a Large Business)
- Statutory Authority: FAR 13.105(a)
- NAICS Code: 325412 – Pharmaceutical Preparation Manufacturing
- Gray Market Items: The Veterans Health Administration prohibits the use of gray market items.
Submission & Evaluation
This is not a request for competitive quotes or proposals. However, all responsible sources may submit a capability statement to demonstrate their ability to provide the requested services. The government will consider these statements before the intended award date.
- Eligibility: Interested sources must be credentialed to prescribe HD drugs, verified by a VA pharmacist, and capable of meeting the specified shipping and delivery requirements.
- Proprietary Information: Must be appropriately marked by the submitter.
- Reimbursement: The government will not reimburse for any information provided.
- Briefings: No requests for capability briefings will be honored.
- Government Discretion: A determination by the Government not to compete this proposed contract based on responses is solely within its discretion.
Key Dates & Contact
- Capability Statement Due: June 17, 2026, by 10:00 AM Eastern Standard Time.
- Submission Email: Morgan.Weeks1@va.gov
- Contracting Officer: Morgan S Weeks, Contract Specialist (Morgan.Weeks1@va.gov, (607) 664-4708)